Genetically engineered salmonella in combination with radiation shown effective against tumors in Yale study

April 03, 2000

(NEW HAVEN) -- Combining Salmonella injections with radiation therapy in mice has shown promising new results for improved cancer treatment. The findings by a team of Yale Cancer Center scientists in collaboration with Vion Pharmaceuticals, New Haven, Conn., were reported at the 91st Annual Meeting of the American Association for Cancer Research in San Francisco today.

The researchers had previously developed a tumor-targeting, genetically-altered strain of Salmonella -- the same bacterium that, in its unaltered or wild type form, can cause food poisoning and septic shock. It was shown to be safe in animal studies, significantly prolonging the lives of mice by suppressing tumor growth. The genetically altered bacteria are currently being tested in Phase I clinical trials with human cancer patients.

"For a number of reasons, we thought that combining these Salmonella with X-ray treatments might be a good strategy for improved therapy," noted John Pawelek, M.D., senior research scientist at the Yale University School of Medicine. "It was exciting to see the positive results."

In a typical experiment, tumor suppression by a combination of X-rays and Salmonella was greater than that seen with either X-rays or Salmonella alone. In fact, the effects of the combination were greater than what would have been expected by the simple addition of the effects of either treatment alone. These results were seen against two different types of melanoma, as well as in colon and breast cancers.

"It appears that the combination of genetically engineered Salmonella with radiotherapy could be a new and beneficial treatment for solid tumors," said Pawelek. "Because of the large number of cancer patients who receive radiation therapy, the potential impact of this finding is tremendous."

Collaborating with Pawelek at Yale were Sara Rockwell, Ph.D. and K. Brooks Low, Ph.D. along with David Bermudes, Ph.D. of Vion Pharmaceuticals.

Yale University

Related Radiation Therapy Articles from Brightsurf:

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

New approach for calculating radiation dosimetry allows for individualized therapy
Researchers have developed a simplified process that could enhance personalization of cancer therapy based on a single nuclear medicine scan.

Developing microbeam radiation therapy (MRT) for inoperable cancer
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients
Researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATATE radiation therapy in a study published in the April issue of The Journal of Nuclear Medicine.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

AI can jump-start radiation therapy for cancer patients
Artificial intelligence can help cancer patients start their radiation therapy sooner -- and thereby decrease the odds of the cancer spreading -- by instantly translating complex clinical data into an optimal plan of attack.

Towards safer, more effective cancer radiation therapy using X-rays and nanoparticles
X-rays could be tuned to deliver a more effective punch that destroys cancer cells and not harm the body.

Radiation therapy effective against deadly heart rhythm
A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at Washington University School of Medicine in St.

New mathematical model can improve radiation therapy of brain tumours
Researchers have developed a new model to optimize radiation therapy and significantly increase the number of tumor cells killed during treatment.

Using artificial intelligence to deliver personalized radiation therapy
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to personalize the dose of radiation therapy used to treat cancer patients.

Read More: Radiation Therapy News and Radiation Therapy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to